Altimmune Inc. (ALT) News Headlines

▮ More

Date

Headline

7/15/2019 7:07:58 AM Altimmune Announces Closing Of Acquisition Of Spitfire Pharma

7/9/2019 7:19:11 AM Altimmune To Acquire Spitfire Pharma

7/9/2019 7:05:14 AM Altimmune Agrees To Acquire Spitfire Pharma; Transaction To Close During July

6/10/2019 8:10:13 AM Altimmune Reports Pre-IND Meeting For HepTcell; Phase 2 Trial To Start In 2020

6/5/2019 8:12:57 AM Altimmune Receives Addl Patent Protection For Its HepTcell And ALT-702 Programs

3/19/2019 7:09:04 AM Altimmune Announces Positive Results From NasoVAX Extension Study

3/7/2019 10:20:55 PM 9 Top Gainers In Healthcare Sector (BPTH, ARQL, SEEL…)

1/29/2019 8:08:42 AM Altimmune Announces Presentation Of HepTcell Phase 1 Results At International Liver Congress™ In Vienna, Austria

1/22/2019 9:05:26 PM 7 Top Gainers In Healthcare Sector (MDWD, RFL, CGEN...)

12/13/2018 9:54:22 PM ALT Hits New Low, FPRX Down 26% This Month, VBIV Prices Stock Offering

12/13/2018 7:04:03 AM Altimmune Announces Clinical Program Updates And Plans For Pipeline Expansion

11/27/2018 9:04:00 AM Altimmune Appoints Vipin Garg As Its President And CEO Succeeding Bill Enright

10/16/2018 8:26:15 PM KRYS Up 53% In 2 Days, SLS To Report Phase 2 Data Next Week, OMED On Watch

10/9/2018 12:01:21 AM AFMD Bleeds On Clinical Hold, BHC Gets FDA Nod, MNLO Disappoints

10/8/2018 9:05:02 AM Altimmune Plans $25 Mln Registered Direct Offering

10/1/2018 8:52:30 PM OGEN Abuzz, NTGN Glows, NEPT On A High, TLRY Back In News

9/24/2018 9:10:40 AM Altimmune Announces $4.9 Mln Registered Direct Offering Of Common Stock

9/20/2018 8:49:54 PM ALT Up 514% In 2 Days, CRBP Well Stocked, ACAD Soars On FDA Review

9/19/2018 9:12:25 PM MTEM Abuzz, TLRY Up 1,240% In 2 Months, ALT Awaits Anthrax Data In Q4

8/31/2018 8:01:49 AM Altimmune Announces Initial Single-Dose Data From Its NasoShield Phase 1 Study